National study of factors influencing assisted reproductive technology outcomes with male factor infertility

Department of Urology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
Fertility and sterility (Impact Factor: 4.3). 07/2011; 96(3):609-14. DOI: 10.1016/j.fertnstert.2011.06.026
Source: PubMed

ABSTRACT To evaluate the outcomes of assisted reproductive technology (ART) cycles for male factor infertility, and method of sperm collection.
Historic cohort study.
Clinic-based data.
Cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System database for 2004 to 2008 were limited to three groups: non-intracytoplasmic sperm injection (ICSI) and ICSI cycles for tubal ligation only; non-ICSI and ICSI cycles for male factor infertility only; and all cycles (regardless of infertility diagnosis) using ICSI only. INTERVENTION(S) AND MAIN OUTCOME MEASURE(S): Multivariate logistic regression was used to model the adjusted odds ratio (AOR) of clinical intrauterine gestation (CIG) and live birth (LB) rates for tubal ligation versus male factor infertility only; ICSI versus non-ICSI for male factor infertility only; and ICSI outcomes based on method of sperm collection.
Models for male factor infertility only versus tubal ligation only ICSI cycles had lower CIG (AOR 0.92) but not LB (AOR 0.87). No difference was seen for non-ICSI cycles. Within male factor infertility only cycles, ICSI had a worse outcome than non-ICSI for CIG (AOR 0.93) but not for LB (AOR 0.94). For all ICSI cycles with no male factor infertility and ejaculated sperm as the reference group, models showed better rates of CIG with male factor infertility ejaculated sperm (AOR 1.07) and with male factor infertility aspirated sperm (AOR 1.09). The LB rate was higher with male factor infertility ejaculated sperm only (AOR 1.04).
The ICSI and sperm source influence CIG and LB rates in male factor infertility cases.

  • [Show abstract] [Hide abstract]
    ABSTRACT: To analyze information on assisted reproductive technology (ART) performed worldwide and trends in outcomes over successive years. Cross-sectional survey on access, effectiveness, and safety of ART procedures performed in 53 countries during 2005. A total of 2,973 clinics from national and regional ART registries. Infertile women and men undergoing ART globally. Collection and analysis of international ART data. Number of cycles performed by country and region, including pregnancies, single and multiple birth rates, and perinatal mortality. Overall, 1,052,363 ART procedures resulted in an estimated 237,315 babies born. The availability of ART varied by country from 15 to 3,982 cycles per million of population. Of all initiated fresh cycles, 62.9% were intracytoplasmic sperm injection. The overall delivery rate per fresh aspiration was 19.6% and for frozen embryo transfer 17.4%, with a cumulative delivery rate of 23.9%. With wide regional variations, single embryo transfer represented 17.5% of cycles, and the proportion of deliveries with twins and triplets from fresh transfers was 23.6% and 1.5%, respectively. Systematic collection and dissemination of international ART data allows patients, health professionals, and policy makers to examine and compare the impact of reproductive strategies or lack of them as markers of reproductive health.
    Fertility and sterility 11/2013; DOI:10.1016/j.fertnstert.2013.10.005 · 4.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Significant progress has been made in several fields of medicine towards personalizing treatment recommendations based on individual patient genotype. As the number of clinical and genetic biomarkers available to physicians has increased, predictive models able to integrate the contributions of multiple variables simultaneously have become valuable tools for medical decision making. Leveraging genotype information and multivariate predictive models holds the promise of bringing greater efficiency to, and reducing the costs of, fertility treatments. This work reviews the advances that have been made in genetic biomarker discovery and predictive modelling for fertility treatment outcomes. We also discuss some of the limitations of these studies for translation to clinical diagnostics and the challenges that remain. Personalized medicine holds the promise of allowing doctors to create ‘bespoke’ treatment recommendations for each patient based on multiple clinical variables such as age and hormone concentrations combined with the patient’s genetic sequence information. A number of challenges remain for the field of reproductive medicine to make the research discoveries necessary to usher in this new era of personalized fertility care. Here, we discuss some of these challenges and make recommendations for overcoming them.
    Reproductive biomedicine online 09/2013; DOI:10.1016/j.rbmo.2013.09.010 · 2.98 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To compare ages of mothers and of fathers at delivery in couples who are fertile, subfertile, and subfertile treated with assisted reproductive technology (ART) and to characterize birth outcomes in the ART population according to paternal age.
    Journal of Assisted Reproduction and Genetics 09/2014; DOI:10.1007/s10815-014-0327-8 · 1.77 Impact Factor

Full-text (2 Sources)

Available from
Jun 6, 2014